Live Chat

Trade Novavax NVAX

Novavax live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2024 Dec 20, 08:40

Wellington Management Group LLP Acquires New Holdings in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 19, 08:26

Novavax adjusts vaccine deal with Australian government By Investing.com

Novavax Inc
Webhose 2024 Dec 19, 03:36

Novavax: Australia Cancels Delivery of Some COVID-19 Doses

Novavax Inc
Webhose 2024 Dec 18, 22:35

Novavax says Australia cancels delivery of some Covid-19 doses

Novavax Inc
Webhose 2024 Dec 18, 11:30

Novavax is as protective as other Covid vaccines, but has fewer side effects | Vox

Novavax Inc
Webhose 2024 Dec 14, 11:12

Tidal Investments LLC Has $6.32 Million Stake in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 13, 13:04

Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50M Milestone By Investing.com

Novavax Inc
Webhose 2024 Dec 13, 05:06

Novavax achieves $50M milestone in Sanofi partnershi By Investing.com

Novavax Inc
Webhose 2024 Dec 12, 10:38

XTX Topco Ltd Boosts Holdings in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 12, 09:47

HC Wainwright Reaffirms “Buy” Rating for Novavax (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 11, 13:48

H.C. Wainwright reiterates Buy on Novavax stock as Phase 3 CIC trial begins By Investing.com

Novavax Inc
Webhose 2024 Dec 11, 00:00

NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines - December 11, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Dec 11, 00:00

FDA Grants Fast Track Tag to SNY's Two COVID & Flu Vaccine Candidates - December 11, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Dec 10, 13:10

Novavax starts Phase 3 trial for dual COVID-19/flu vaccine By Investing.com

Novavax Inc
Webhose 2024 Dec 10, 05:06

Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza By Investing.com

Novavax Inc
Webhose 2024 Dec 10, 00:00

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - December 10, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Dec 08, 10:11

Two Sigma Advisers LP Has $25.25 Million Stake in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 08, 08:28

BNP Paribas Financial Markets Cuts Stock Holdings in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 07, 17:01

Novavax (NASDAQ:NVAX) Trading Up 10.1% - Time to Buy?

Novavax Inc
Webhose 2024 Dec 06, 16:38

Stock Traders Purchase High Volume of Call Options on Novavax (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 06, 16:33

Brokerages Set Novavax, Inc. (NASDAQ:NVAX) Target Price at $17.83

Novavax Inc
Webhose 2024 Dec 06, 13:38

Investors Purchase High Volume of Novavax Call Options (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 05, 00:00

Novavax to Sell Czech Manufacturing Plant to Novo Nordisk for $200M - December 5, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Dec 04, 11:52

Novavax sells Czech facility to Novo Nordisk for $200 million By Investing.com

Novavax Inc
Webhose 2024 Dec 04, 10:38

Edgestream Partners L.P. Acquires New Holdings in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 04, 10:08

Novavax sells Czech manufacturing facility to Novo Nordisk for $200 mln By Investing.com

Novavax Inc
Webhose 2024 Dec 04, 09:56

Edgestream Partners L.P. Makes New Investment in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Dec 04, 09:27

Novavax Rallies on Sale of Czech Facility to Novo Nordisk (1)

Novavax Inc
Webhose 2024 Dec 04, 09:04

Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 mln

Novavax Inc
Webhose 2024 Dec 04, 08:32

Novavax To Sell Manufacturing Facility In Bohumil, Czech Republic To Novo Nordisk For $200 Mln

Novavax Inc
Webhose 2024 Dec 04, 07:00

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 Million | Morningstar

Novavax Inc
Webhose 2024 Dec 04, 06:35

Novavax sells Czech manufacturing facility to Novo Nordisk for $200 mn | World News - Business Standard

Novavax Inc
Webhose 2024 Nov 29, 09:44

Bank of Montreal Can Purchases 517,727 Shares of Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Nov 29, 07:08

Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of “Hold” by Brokerages

Novavax Inc
Webhose 2024 Nov 29, 07:08

Novavax, Inc. (NASDAQ:NVAX) Receives Average Rating of "Hold" from Analysts

Novavax Inc
Webhose 2024 Nov 26, 00:00

Novavax and Assembly lead infectious disease gainers in 2024 | BioWorld

Novavax Inc

Latest news

Frances Wang 2024 Dec 19, 16:00

Analyst revises Amazon stock forecast following major 'moonshot' initiative

Stocks
Frances Wang 2024 Dec 19, 16:00

Stock market today: 3 bullish stocks that J.P. Morgan Just Upgraded

Stocks
Frances Wang 2024 Dec 19, 16:00

Bitcoin news today: Jerome Powell Says Fed Won’t Hold Bitcoin

Cryptocurrencies
Frances Wang 2024 Dec 19, 16:00

Gold performance and prediction: how high could gold price go?

Commodities
UK GDP
Dyogenes Diniz 2024 Dec 19, 16:00

Week ahead: Last full week of 2024 in the Financial Markets

Forex Indices
Frances Wang 2024 Dec 18, 16:00

Stock market today: Nasdaq Hits Record Highs as Tesla Achieves New Peaks

Stocks
Frances Wang 2024 Dec 18, 16:00

Dow Jones tumbles 1,100 points: why did the stock market go down today?

Stocks
Frances Wang 2024 Dec 18, 16:00

Super Micro Shares Drop 8% Following Nasdaq 100 Removal

Stocks

Info

Spread

0.07

Spread (%)

0.8083 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-17:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1393609344

Shares Outstanding

160184992

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-2.18

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments
Trustpilot
Live Chat